Raymond E. Cabillot Sells 5,151 Shares of Pro-Dex, Inc. (NASDAQ:PDEX) Stock

Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot sold 5,151 shares of the business’s stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $50.00, for a total transaction of $257,550.00. Following the transaction, the director now directly owns 300,695 shares of the company’s stock, valued at $15,034,750. The trade was a 1.68 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Pro-Dex Trading Up 1.8 %

Shares of NASDAQ:PDEX opened at $49.78 on Wednesday. The company has a 50 day moving average of $39.75 and a 200-day moving average of $38.66. The firm has a market cap of $162.33 million, a P/E ratio of 24.77 and a beta of 0.68. Pro-Dex, Inc. has a twelve month low of $16.84 and a twelve month high of $59.60. The company has a current ratio of 2.58, a quick ratio of 1.44 and a debt-to-equity ratio of 0.33.

Pro-Dex (NASDAQ:PDEX) last issued its quarterly earnings results on Thursday, January 30th. The medical instruments supplier reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.23. Pro-Dex had a net margin of 11.06% and a return on equity of 21.68%. As a group, analysts anticipate that Pro-Dex, Inc. will post 2 earnings per share for the current fiscal year.

Institutional Trading of Pro-Dex

A number of institutional investors have recently made changes to their positions in PDEX. FMR LLC raised its holdings in shares of Pro-Dex by 34.9% in the 3rd quarter. FMR LLC now owns 3,973 shares of the medical instruments supplier’s stock worth $119,000 after purchasing an additional 1,028 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in shares of Pro-Dex in the 4th quarter worth approximately $202,000. Trexquant Investment LP bought a new stake in shares of Pro-Dex in the 4th quarter worth approximately $252,000. Integrated Quantitative Investments LLC bought a new stake in shares of Pro-Dex in the 4th quarter worth approximately $254,000. Finally, Arrowstreet Capital Limited Partnership bought a new stake in shares of Pro-Dex in the 4th quarter worth approximately $255,000. 15.28% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered shares of Pro-Dex from a “buy” rating to a “hold” rating in a research note on Wednesday, March 12th.

Pro-Dex Company Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.